AI Daily Briefing — 2026-06-15

A biotech company called Life Biosciences has injected an experimental treatment into the eye of a glaucoma patient, aiming to regenerate damaged nerves and restore vision. The trial marks a significant step in the field of aging research, with company chairman David Sinclair suggesting that if the approach works for glaucoma, it could eventually be used to reverse other age-related diseases—and perhaps aging itself. The treatment relies on “reprogramming” cells to a younger state, a strategy that is gaining momentum among longevity scientists.

Reprogramming is based on Nobel Prize-winning research showing that four genetic factors can turn adult cells into stem cells, which can then develop into any cell type. In mouse studies, this technique has improved tissue healing and restored vision, fueling excitement. However, other once-popular aging targets have faded. Telomere shortening, once a hot topic, lost steam after early hype, while “senolytic” drugs that clear out zombie-like senescent cells failed in human trials, leading to the shutdown of Unity Biotechnology.

Despite these setbacks, reprogramming has become the buzziest approach in the aging field today. Researchers hope that by resetting cells to a youthful state, they can tackle the root causes of age-related decline. While the path is uncertain, the recent human trial signals a shift from lab experiments to real-world testing, with many watching closely to see if this bold strategy can deliver on its promise.

Source: MIT Technology Review AI

Your brain operates in the dark, yet it constantly monitors signals from your body—the flutter of your heart, the clench of your gut, the sweat on your palms. This internal awareness, known as interoception, processes a staggering 11 million bits of sensory data each second, though only a tiny fraction reaches conscious thought. Researchers estimate the conscious mind handles just 10 to 60 bits per second, a mercy that allows us to function without being overwhelmed. As Moriah Thomason, a neuroscientist at NYU Langone, explains, we are built to hold only a limited amount in mind at any time.

The term interoception was coined in 1906 by neurophysiologist Charles Sherrington, but it remained obscure for most of the 20th century. Today, spurred by a 2021 Nobel Prize and new mapping tools, the field is experiencing a renaissance. Scientists are decoding how signals travel between body and brain, with implications for treating conditions like obesity, chronic pain, and anxiety. In 1994, neurologist Antonio Damasio challenged the separation of thinking and feeling in his book 'Descartes’ Error,' arguing that emotions, rooted in bodily signals, drive decision-making. Without this connection, reason falters.

Neuroscientist Bud Craig spent his career exploring how the brain builds a real-time inner map of the body—like a starship captain's bridge monitoring critical systems. This hidden sense shapes our choices and well-being, from the growl of hunger to the calm of a steady breath. As research advances, interoception promises to unlock new ways to understand and heal the mind-body connection.

Anthropic's abrupt suspension of its latest AI models following a U.S. government directive has ignited a fierce debate in India about technological dependence. The decision, which blocks access to the Fable 5 and Mythos 5 models for foreign nationals—including Anthropic's own employees abroad—came just after the company announced a major partnership with Indian IT giant Tata Consultancy Services. This timing has underscored how deeply India's AI ambitions are tied to American-controlled technology, prompting urgent questions about the nation's long-term strategy.

For Indian founders, investors, and policy experts, the episode has become a wake-up call. Aakrit Vaish, founder of AI venture platform Activate, described waking up "shocked and confused" by the announcement, arguing it "materially changes the way all of us should be thinking about sovereign AI in India." He now plans to push portfolio companies toward open-source alternatives. Vijay Rayapati, CEO of Atomicwork, warned that startups with multinational teams face new risks if access to frontier AI becomes subject to geopolitical restrictions.

India has become the second-largest market for both Anthropic and OpenAI, with offices, local hiring, and enterprise initiatives expanding rapidly. The suspension has reopened fundamental questions: Should India accelerate domestic AI development, deepen investment in open-source models, or continue relying on a handful of U.S. providers? For many, the answer is becoming clearer—that access to critical AI systems can be shaped by decisions far beyond India's control, making self-reliance an urgent priority.

A biotech firm, Life Biosciences, has begun human trials for an experimental glaucoma treatment that aims to regenerate healthy nerves in the eye. The company hopes this approach, which involves “reprogramming” cells to a younger state, could eventually treat other age-related diseases and even reverse aging itself. This strategy is gaining traction among biotech companies focused on slowing or reversing the aging process, as reported by MIT Technology Review AI.

Meanwhile, scientists are exploring interoception, the body’s internal sense of itself. Research into how signals travel between the body and brain has accelerated since a 2021 Nobel Prize, with new tools mapping these internal pathways. Understanding interoception could lead to better treatments for conditions like obesity, chronic pain, and anxiety, opening up what researchers call a “new continent of awareness.”

These developments highlight two frontiers in science: one aiming to reprogram our biology to combat aging, and another decoding the hidden sense of how we feel from within. Both fields promise to reshape our understanding of health and disease, according to MIT Technology Review AI.

In the stifling heat of a white desert noon, three librarians stood guard in their remote library. Little Jo, Eustace, and the narrator, Ponyboy, were ready for trouble when a stranger staggered through the open door. The wanderer collapsed on the threshold, gasping for sanctuary. The librarians dragged them inside, stripped off their city-made clothes, and rushed them to the cool cellar. Packing ice around the heat-sick traveler, they worked to lower their temperature. The stranger, who called herself Gibson, fought briefly before surrendering to their care. Ponyboy assured her she had reached the Bōchord, a place of refuge. The librarians knew pursuit might follow, but for now, they focused on saving a life. The cellar, stocked with homemade lager and preserved food, became a haven. Mehitabel the cat watched from above, indifferent to the human drama unfolding below. Little Jo returned to guard the entrance, ready for whatever came next. The library stood silent in the heat, a sanctuary in a harsh world.